In our Regulatory Snapshot, when we say a country treats Medicinal Cannabis as restricted, it means that products like cannabidiol (CBD) oils are only allowed under formal medicine registration rules. This does not exclude other interpretations, where the same CBD oil may be seen as a herbal medicine, supplement, or even a superfood. In many countries, this remains a “grey area” — a space where entrepreneurs must actively engage and help shape the path forward.
What you'll learn
Table of contents
India Introduction
India regulates cannabis primarily through the NDPS Act, which prohibits ganja/charas (flower/resin) while allowing state-controlled sale of bhang (leaf-based preparations) in certain jurisdictions. A limited medical pathway exists through AYUSH (traditional medicine) where licensed manufacturers produce Vijaya (Cannabis sativa) extracts and Rx-only formulations for specific indications under state/central approvals. Several states permit industrial hemp under license—commonly adopting a ≤0.3% THC benchmark. CBD is not approved as a food/supplement by FSSAI; channels observed in-market rely on AYUSH prescription products or non-cannabinoid hemp seed ingredients. Psilocybin remains prohibited.
---
Cannabis & Wellness Regulation Overview
Recreational Cannabis (Adult Use)
Status: Illegal under NDPS.
- Possession, cultivation, and sale of cannabis (flower/resin) are criminal offences.
- Bhang (leaf-based) may be sold in some states via licensed outlets; rules vary by state.
- Public consumption and trafficking are strictly penalized.
Medical Cannabis (AYUSH Pathway)
Status: Limited, physician-supervised, Rx-only.
- AYUSH-licensed products using Vijaya extract may be manufactured/distributed with state permissions.
- Prescriptions typically issued by AYUSH practitioners; allopathic use is limited to specific, approved products.
- No broad “medical cannabis card” system; pharmacy-like access is not generalized.
- Clinical claims and indications must align with approved AYUSH formulations and labeling.
Hemp Definition & Industrial Use
Status: Permitted under state licensing.
- States such as Uttarakhand pioneered industrial hemp frameworks; others have followed with pilot/controlled programs.
- Policies typically set ≤0.3% THC in the field; licensing governs cultivation, transport, and processing.
- Seed, fiber, hurd, and hemp seed oil/flour are common focus areas.
CBD Products
Status: Channel-specific, not approved as food.
- FSSAI recognizes hemp seed, hemp seed oil, and hemp seed flour as foods with THC/contaminant limits.
- CBD (cannabinoid) ingestibles are not approved as foods/supplements.
- AYUSH route: CBD-containing preparations can exist only as AYUSH proprietary/ classical medicines with appropriate licenses, Rx, and compliant claims.
- Borderline/e-commerce sales occur but face enforcement risk.
Cosmetics & Artisanal Products
Status: Permitted without cannabinoids.
- Hemp seed oil (no cannabinoids) is acceptable in cosmetics.
- CBD/THC ingredients are not permitted in cosmetics.
- All cosmetics must comply with Drugs & Cosmetics Rules (labeling, safety, manufacturer license as applicable).
Functional Mushrooms & Adaptogens
Status: Permitted.
- Reishi, lion’s mane, cordyceps and other adaptogens are marketed under FSSAI as foods/supplements.
- Claims limited to nutrition/wellness; no disease-curing statements.
Psilocybin / Psychedelics
Status: Prohibited.
- Psilocybin is controlled under NDPS; no medical, decriminalized, or retail framework.
- Research requires extraordinary approvals; commercial sale is illegal.
---
Operating Guidance (Hemp Vegan)
Wellness-Driven Coffee & Retail
Compliance-first entry lanes in India:
- Choose your space: cafés/hubs anchored in coffee, teas, superfoods, functional mushrooms, and hemp seed foods (no cannabinoids).
- Plug into the ecosystem: collaborate with state-licensed hemp processors for seed/flour/oil; vet AYUSH manufacturers where clinically appropriate.
- Grow with support: SOPs for AYUSH Rx processes, FSSAI labeling, and staff compliance training (no casual CBD claims).
Clinical Tools & AI
- Clinician-facing tools to gate by channel (AYUSH vs. food vs. cosmetic), flagging NDPS risks.
- Dosing libraries limited to approved AYUSH formulations; interaction/contraindication prompts.
- Intake and documentation templates aligned with AYUSH standards.
---
Marketing, Claims & Compliance
Advertising & Claims
- No therapeutic claims unless explicitly permitted under AYUSH approvals.
- For hemp seed foods/cosmetics: use nutrition/skin-care language; avoid cannabinoid references.
- Maintain age-appropriate positioning; avoid any “intoxication” messaging.
Packaging & Labeling
- AYUSH medicines: license number, dosage, indications per approval, batch/expiry, manufacturer.
- FSSAI foods/supplements: nutrition facts, allergen, batch/expiry, FSSAI license number, importer (if any).
- Cosmetics: ingredient (INCI/common), batch, Mfd/Use-by, responsible firm details.
---
Taxes, Import & Duties
- GST: slabs from 0–28%; many wellness goods fall at 18%.
- AYUSH medicines may fall under different GST slabs (commonly 12%); confirm HSN at time of listing.
- Import of CBD/cannabis products is not permitted except under specific AYUSH/NDPS exemptions; hemp seed foods importable with FSSAI compliance.
---
Risks & Practical Notes
- NDPS exposure is the primary risk—strictly avoid non-compliant cannabinoids.
- AYUSH path is viable but documentation-heavy (licenses, Rx, approved indications).
- Hemp seed foods and functional mushrooms are the safest scalable categories.
- Strategy: start with mushrooms + hemp seed foods/cosmetics, add AYUSH partnerships where clinical oversight exists.
---
FAQ (Hemp Vegan)
Is recreational cannabis legal in India?
No. Recreational cannabis remains illegal under the NDPS Act. Some states permit bhang (leaf-based) via licensed outlets.
Can I sell CBD oil as a supplement?
Not as a food/supplement. CBD can only appear in AYUSH-licensed, Rx-only medicines with proper approvals.
Is hemp cultivation legal?
Yes, where state licenses allow it (industrial hemp, typically ≤0.3% THC in policy). Rules vary by state.
---
Sources & Review Log
_Last reviewed_: 2025-08-23
_Sources to maintain on file_:
- NDPS Act & Rules — cannabis/derivatives control (incl. state permissions for medical/industrial use).
- AYUSH Ministry guidance — licensing of Vijaya-based proprietary/classical medicines.
- FSSAI notifications — recognition of hemp seed, seed oil, seed flour as food ingredients; cannabinoid exclusions.
- State hemp policies — e.g., Uttarakhand (industrial hemp licensing) and other adopting states.
- Drugs & Cosmetics Rules — cosmetics compliance (no cannabinoids).
